openPR Logo
Press release

Corticosteroids Marketย is anticipated to generate an estimated revenue of USD 8.53 billion by 2032 | Latest Reports by Polaris Market Research

06-17-2024 01:07 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Corticosteroids Market

Corticosteroids Market

๐‘ฎ๐’๐’๐’ƒ๐’‚๐’ ๐‘ช๐’๐’“๐’•๐’Š๐’„๐’๐’”๐’•๐’†๐’“๐’๐’Š๐’…๐’” ๐‘ด๐’‚๐’“๐’Œ๐’†๐’• ๐’”๐’Š๐’›๐’† ๐’‚๐’๐’… ๐’”๐’‰๐’‚๐’“๐’† ๐’Š๐’” ๐’„๐’–๐’“๐’“๐’†๐’๐’•๐’๐’š ๐’—๐’‚๐’๐’–๐’†๐’… ๐’‚๐’• ๐‘ผ๐‘บ๐‘ซ 5.96 ๐’ƒ๐’Š๐’๐’๐’Š๐’๐’ ๐’Š๐’ 2024 ๐’‚๐’๐’… ๐’Š๐’” ๐’‚๐’๐’•๐’Š๐’„๐’Š๐’‘๐’‚๐’•๐’†๐’… ๐’•๐’ ๐’ˆ๐’†๐’๐’†๐’“๐’‚๐’•๐’† ๐’‚๐’ ๐’†๐’”๐’•๐’Š๐’Ž๐’‚๐’•๐’†๐’… ๐’“๐’†๐’—๐’†๐’๐’–๐’† ๐’๐’‡ ๐‘ผ๐‘บ๐‘ซ 8.53 ๐’ƒ๐’Š๐’๐’๐’Š๐’๐’ ๐’ƒ๐’š 2032, ๐’‚๐’„๐’„๐’๐’“๐’…๐’Š๐’๐’ˆ ๐’•๐’ ๐’•๐’‰๐’† ๐’๐’‚๐’•๐’†๐’”๐’• ๐’”๐’•๐’–๐’…๐’š ๐’ƒ๐’š ๐‘ท๐’๐’๐’‚๐’“๐’Š๐’” ๐‘ด๐’‚๐’“๐’Œ๐’†๐’• ๐‘น๐’†๐’”๐’†๐’‚๐’“๐’„๐’‰. ๐‘ฉ๐’†๐’”๐’Š๐’…๐’†๐’”, ๐’•๐’‰๐’† ๐’“๐’†๐’‘๐’๐’“๐’• ๐’๐’๐’•๐’†๐’” ๐’•๐’‰๐’‚๐’• ๐’•๐’‰๐’† ๐’Ž๐’‚๐’“๐’Œ๐’†๐’• ๐’†๐’™๐’‰๐’Š๐’ƒ๐’Š๐’•๐’” ๐’‚ ๐’“๐’๐’ƒ๐’–๐’”๐’• 4.6% ๐‘ช๐’๐’Ž๐’‘๐’๐’–๐’๐’… ๐‘จ๐’๐’๐’–๐’‚๐’ ๐‘ฎ๐’“๐’๐’˜๐’•๐’‰ ๐‘น๐’‚๐’•๐’† (๐‘ช๐‘จ๐‘ฎ๐‘น) ๐’๐’—๐’†๐’“ ๐’•๐’‰๐’† ๐’‡๐’๐’“๐’†๐’„๐’‚๐’”๐’•๐’†๐’… ๐’•๐’Š๐’Ž๐’†๐’‡๐’“๐’‚๐’Ž๐’†, 2024 - 2032

The corticosteroids market is a significant segment within the pharmaceutical industry, focusing on the production and distribution of corticosteroid drugs. These drugs are synthetic versions of hormones produced by the adrenal cortex and are used to treat a wide range of medical conditions due to their anti-inflammatory and immunosuppressive properties. They are commonly prescribed for conditions such as asthma, arthritis, lupus, and skin disorders, among others.

๐‘ฎ๐’‚๐’Š๐’ ๐’†๐’™๐’‘๐’†๐’“๐’• ๐’Š๐’๐’”๐’Š๐’ˆ๐’‰๐’•๐’” ๐’‚๐’๐’… ๐’”๐’–๐’‘๐’†๐’“๐’„๐’‰๐’‚๐’“๐’ˆ๐’† ๐’š๐’๐’–๐’“ ๐’ˆ๐’“๐’๐’˜๐’•๐’‰ ๐’”๐’•๐’“๐’‚๐’•๐’†๐’ˆ๐’Š๐’†๐’”. ๐‘น๐’†๐’’๐’–๐’†๐’”๐’• ๐’๐’–๐’“ ๐’Ž๐’‚๐’“๐’Œ๐’†๐’• ๐’๐’—๐’†๐’“๐’—๐’Š๐’†๐’˜ ๐’”๐’‚๐’Ž๐’‘๐’๐’† ๐’๐’๐’˜: https://www.polarismarketresearch.com/industry-analysis/corticosteroids-market/request-for-sample
Market Size and Growth

The global corticosteroids market has been experiencing steady growth, driven by increasing incidences of chronic diseases, rising awareness of corticosteroid treatments, and advancements in drug formulations. As of the latest reports, the market is valued at several billion dollars, with expectations for continued growth over the next decade.

๐Œ๐š๐ฃ๐จ๐ซ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

AbbVie Inc.
Astellas Pharma Inc.
AstraZeneca plc
Bausch Health Companies Inc.
Bayer AG
Cipla Limited
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Johnson & Johnson
Lupin Limited
Merck & Co., Inc.
Novartis International AG
Pfizer Inc.
Sanofi S.A.

๐‘ฌ๐’™๐’‘๐’๐’๐’“๐’† ๐‘ฐ๐’-๐‘ซ๐’†๐’‘๐’•๐’‰ ๐‘ด๐’‚๐’“๐’Œ๐’†๐’• ๐‘จ๐’๐’‚๐’๐’š๐’”๐’Š๐’”: ๐‘ท๐’–๐’“๐’„๐’‰๐’‚๐’”๐’† ๐‘ต๐’๐’˜ ๐’•๐’ ๐‘จ๐’„๐’„๐’†๐’”๐’” ๐‘บ๐’†๐’ˆ๐’Ž๐’†๐’๐’•-๐’”๐’‘๐’†๐’„๐’Š๐’‡๐’Š๐’„ ๐‘ซ๐’†๐’•๐’‚๐’Š๐’๐’”, ๐‘ผ๐’๐’„๐’๐’—๐’†๐’“ ๐‘ช๐’“๐’–๐’„๐’Š๐’‚๐’ ๐‘ป๐’“๐’†๐’๐’…๐’”, ๐‘ซ๐’“๐’Š๐’—๐’†๐’“๐’”, ๐’‚๐’๐’… ๐‘ช๐’‰๐’‚๐’๐’๐’†๐’๐’ˆ๐’†๐’”: https://www.polarismarketresearch.com/buy/3254/2

๐‘๐ž๐œ๐ž๐ง๐ญ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐‚๐จ๐ซ๐ญ๐ข๐œ๐จ๐ฌ๐ญ๐ž๐ซ๐จ๐ข๐๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

The corticosteroids market has seen notable developments recently, driven by advancements in pharmaceutical research, regulatory changes, and market dynamics. Here's a detailed overview of the latest trends and developments:

๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ง ๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ž๐ฅ๐ข๐ฏ๐ž๐ซ๐ฒ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ๐ฌ:
Pharmaceutical companies are increasingly focusing on improving the delivery mechanisms of corticosteroids. Innovations such as inhalers, nasal sprays, topical formulations, and sustained-release injectables have enhanced the efficacy and patient compliance. The development of nanotechnology-based delivery systems is particularly noteworthy, as it allows for targeted drug delivery and reduced side effects.

๐ˆ๐ง๐ญ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐๐ข๐จ๐ฌ๐ข๐ฆ๐ข๐ฅ๐š๐ซ ๐‚๐จ๐ซ๐ญ๐ข๐œ๐จ๐ฌ๐ญ๐ž๐ซ๐จ๐ข๐๐ฌ:
The introduction of biosimilar corticosteroids has been a significant development. These biosimilars offer similar therapeutic benefits to their branded counterparts but at a reduced cost, thereby increasing accessibility for patients. Regulatory bodies like the FDA and EMA have approved several biosimilar corticosteroids, which are expected to drive market growth.

๐„๐ฑ๐ฉ๐š๐ง๐๐ž๐ ๐ˆ๐ง๐๐ข๐œ๐š๐ญ๐ข๐จ๐ง๐ฌ ๐š๐ง๐ ๐€๐ฉ๐ฉ๐ซ๐จ๐ฏ๐š๐ฅ๐ฌ:
Recent approvals for corticosteroids in treating a broader range of conditions have expanded the market. Conditions such as chronic obstructive pulmonary disease (COPD), certain cancers, and autoimmune diseases are now increasingly being treated with corticosteroids. This has broadened the application of these drugs beyond their traditional use in inflammatory and allergic conditions.

๐‚๐จ๐ซ๐ญ๐ข๐œ๐จ๐ฌ๐ญ๐ž๐ซ๐จ๐ข๐๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ

In 2023, the glucocorticoids segment accounted for significant market share owing to versatility, management of chronic diseases, and therapeutic advancements.

In 2023, the topical segment accounted for significant market share owing to reduced systemic absorption, localized treatment, and compatibility with other therapies.

In 2023, the skin allergies segment held significant revenue share owing to anti-inflammatory properties, quick symptomatic relief, and wide range of applications.

In 2023, North America region dominated the global market due to established players, regulatory environment, ongoing technological advancements, and research and development.

The market is highly competitive owing to the existence of market players with a global presence, including AbbVie Inc., AstraZeneca plc, Bayer AG, Cipla Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, and Sanofi S.A. among others.

๐‘จ๐’„๐’„๐’†๐’”๐’” ๐’•๐’‰๐’† ๐‘ญ๐’–๐’๐’ ๐‘น๐’†๐’‘๐’๐’“๐’•, ๐’‰๐’†๐’“๐’†: https://www.polarismarketresearch.com/industry-analysis/corticosteroids-market

Polarisย Market Research has segmented the Corticosteroids market report based on type, route of administration, application, and region:

Corticosteroids, Type Outlook (Revenueย -ย USD Billion, 2019 - 2032)

Mineralocorticoids
Glucocorticoids

Corticosteroids, Route of Administration Outlook (Revenueย -ย USD Billion, 2019 - 2032)

Inhaled
Topical
Injectable
Oral

Corticosteroids, Application Outlook (Revenueย -ย USD Billion, 2019 - 2032)

Skin Allergies
Gastroenterology
Endocrinology
Acute Respiratory Diseases
Rheumatology Indications
Others

Corticosteroids, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
S.
Canada
Europe
France
Germany
UK
Italy
Netherlands
Spain
Russia
Asia Pacific
Japan
China
India
Malaysia
Indonesia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

๐„๐๐“ ๐๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/ent-devices-market

๐๐ก๐š๐ซ๐ฆ๐š๐œ๐จ๐ ๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/pharmacogenomics-market

๐€๐ง๐ญ๐ข-๐Ž๐›๐ž๐ฌ๐ข๐ญ๐ฒ ๐Œ๐ž๐๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/anti-obesity-medication-market

๐–๐ž๐š๐ซ๐š๐›๐ฅ๐ž ๐ˆ๐ง๐ฃ๐ž๐œ๐ญ๐จ๐ซ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/wearable-injectors-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐ˆ๐ง๐Ÿ๐จ:
Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Corticosteroids Marketย is anticipated to generate an estimated revenue of USD 8.53 billion by 2032 | Latest Reports by Polaris Market Research here

News-ID: 3541333 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Endoscopic Hemostasis Devices Market Soars to US$ 2,954.80 Million With Experiencing a 3.6% CAGR Boosted by Industry Key Players From 2025 to 2034
Endoscopic Hemostasis Devices Market Soars to US$ 2,954.80 Million With Experien โ€ฆ
The endoscopic hemostasis devices market report offers an in-depth analysis of the rapidly growing market. It covers all the key market aspects, including market share, size, trends, and recent developments. In addition, the report assesses top regions, key segments, and the competitive landscape of the market. The global endoscopic hemostasis devices market was valued at USD 2,066.92 million in 2024. With a compound annual growth rate (CAGR) of 3.6% fromโ€ฆ
Wind Turbine Composites Market to Surge to US$ 31.88 Billion at a CAGR of 8.54% Forecast by 2025-2034
Wind Turbine Composites Market to Surge to US$ 31.88 Billion at a CAGR of 8.54% โ€ฆ
Polaris Market Research announces the release of its latest research report titled, "Wind Turbine Composites Market Size, Share, & Industry Analysis Report: By Fiber Type (Glass Fiber, Carbon Fiber, and Others), By Application, By Manufacturing Process, and By Region - Market Forecast, 2025-2034." The report examines the market for wind turbine composites to exhibit a CAGR of 8.54% during 2025-2034. The market was valued at USD 14.07 billion in 2024 andโ€ฆ
Gas Separation Membrane Market Size Projected to Reach USD 1,911.34 Million by 2034, Growing at a CAGR of 6.80%
Gas Separation Membrane Market Size Projected to Reach USD 1,911.34 Million by 2 โ€ฆ
Gas Separation Membrane Market: The latest research report on the gas separation membrane market by Polaris Market Research offers an in-depth comprehension of a rapidly evolving sector. It covers all the key market aspects, including market share, size, trends, and recent developments. In addition, an in-depth analysis of the key regions, major segments, and competitive landscape has been provided. The market for gas separation membrane was valued at USD 998.24 million inโ€ฆ
Global E-fuel Market Predicted to Reach USD 900.80 Billion by 2034, Growing at 18.9%
Global E-fuel Market Predicted to Reach USD 900.80 Billion by 2034, Growing at 1 โ€ฆ
E-fuel Market Polaris Market Research announces the release of its latest research report titled, "E-fuel Market Size, Share, & Industry Analysis Report: By State (Liquid and Gas), By Fuel Type, By Production, By End User, and By Region - Market Forecast, 2025-2034." The report analyzes the market for e-fuel to exhibit a compound annual growth rate (CAGR) of 18.9% during 2025-2034. The market was valued at USD 159.85 billion in 2024 andโ€ฆ

All 5 Releases


More Releases for Corticosteroids

Intranasal Corticosteroids Market 2021 | Detailed Report
ReportsnReports publishes the report titled Intranasal Corticosteroids that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like cost,โ€ฆ
Global Corticosteroids Therapy Market | Global Corticosteroids Therapy Industry โ€ฆ
The corticosteroids therapy market comprises of sales of artificial corticosteroid drugs utilized to treat a wide variety of syndromes, including asthma, arthritis, skin conditions, and autoimmune diseases and lowers inflammation in the body. Corticosteroids and their biologically active synthetic derivatives vary in their metabolic (glucocorticoid) and electrolyte-regulating (mineralocorticoid) activities. These agents are active at physiological doses for additional therapy when endogenous manufacture is impaired. The market involves of revenue createdโ€ฆ
Corticosteroids Market Growth, Size, Opportunity, Share and Forecast 2019-2025
The global Corticosteroids market is estimated to grow at a CAGR of nearly 4.8% during the forecast period. Rising demand for topical and inhaled Corticosteroids is primarily encouraging the growth of the market. Increasing prevalence of skin allergies and acute respiratory disorders has significantly increased the adoption of topical and inhaled Corticosteroids. In 2018, the number of children under age 18 years with reported skin allergies in the US wasโ€ฆ
Corticosteroids Market To Register Substantial Expansion By 2026
Corticosteroids are a set of steroid hormones which are either produced in the adrenal cortex or are made synthetically. Corticosteroids produced naturally are known as systemic steroids, while those produced chemically are called synthetic steroids. Systemic steroids are given either orally or by injection. View Report : https://www.transparencymarketresearch.com/corticosteroids-market.html Adrenal cortex, found along the perimeter of the adrenal glands, produce two main corticosteroids, cortisol and aldosterone. When the adrenal glands stop producingโ€ฆ
Intranasal Corticosteroids Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on Intranasal Corticosteroids Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Intranasal Corticosteroids market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,โ€ฆ
Corticosteroids Market 2019: Rising Demand for Topical Corticosteroids, and Surg โ€ฆ
Factors driving the growth of the global corticosteroids market include growing geriatric population, increasing incidence of chronic diseases, rising demand for topical corticosteroids, and surging investment in research and development. Companies are increasingly participating in mergers and acquisitions to strengthen their position in the market. Their increasing R&D investments are also expected to drive the corticosteroids market in the near future. However, government is putting pricing pressure on the companiesโ€ฆ